scholarly journals Metabolic effects of Tofogliflozin are efficiently enhanced with appropriate dietary carbohydrate ratio and are distinct from carbohydrate restriction

2018 ◽  
Vol 6 (5) ◽  
pp. e13642 ◽  
Author(s):  
Shiori Ito ◽  
Toshio Hosaka ◽  
Wataru Yano ◽  
Takahiro Itou ◽  
Misako Yasumura ◽  
...  
2005 ◽  
Vol 289 (2) ◽  
pp. E306-E312 ◽  
Author(s):  
Matthew P. Harber ◽  
Simon Schenk ◽  
Ariel L. Barkan ◽  
Jeffrey F. Horowitz

Dietary carbohydrate restriction (CR) presents a challenge to glucose homeostasis. Despite the popularity of CR diets, little is known regarding the metabolic effects of CR. The purpose of this study was to examine changes in whole body carbohydrate oxidation, glucose availability, endogenous glucose production, and peripheral glucose uptake after dietary CR, without the confounding influence of a negative energy balance. Postabsorptive rates of glucose appearance in plasma (Ra; i.e., endogenous glucose production) and disappearance from plasma (Rd; i.e., glucose uptake) were measured using isotope dilution methods after a conventional diet [60% carbohydrate (CHO), 30% fat, and 10% protein; kcals = 1.3 × resting energy expenditure (REE)] and after 2 days and 7 days of CR (5% CHO, 60% fat, and 35% protein; kcals = 1.3 × REE) in eight subjects (means ± SE; 29 ± 4 yr; BMI 24 ± 1 kg/m2) during a 9-day hospital visit. Postabsorptive plasma glucose concentration was reduced ( P = 0.01) after 2 days but returned to prediet levels the next day and remained at euglycemic levels throughout the diet (5.1 ± 0.2, 4.3 ± 0.3, and 4.8 ± 0.4 mmol/l for prediet, 2 days and 7 days, respectively). Glucose Ra and glucose Rd were reduced to below prediet levels (9.8 ± 0.6 μmol·kg−1·min−1) after 2 days of CR (7.9 ± 0.3 μmol·kg−1·min−1) and remained suppressed after 7 days (8.3 ± 0.4 μmol·kg−1·min−1; both P < 0.001). A greater suppression in carbohydrate oxidation, compared with the reduction in glucose Rd, led to an increased (all P ≤ 0.05) rate of nonoxidative glucose disposal at 7 days (5.2 ± 0.5 μmol·kg−1·min−1), compared with 2 days (2.7 ± 0.5 μmol·kg−1·min−1) and prediet (1.6 ± 0.8 μmol·kg−1·min−1). In response to eucaloric CR, a marked increase in nonoxidative glucose disposal may help maintain systemic glucose availability.


2008 ◽  
Vol 22 (S1) ◽  
Author(s):  
Richard S Bruno ◽  
Moises Torres‐Gonzalez ◽  
Steven F Yeung ◽  
Steven R Davis ◽  
Jeff S Volek ◽  
...  

Nutrition ◽  
2019 ◽  
Vol 62 ◽  
pp. 213 ◽  
Author(s):  
Richard D. Feinman ◽  
Wendy K. Pogozelski ◽  
Arne Astrup ◽  
Richard K. Bernstein ◽  
Eugene J. Fine ◽  
...  

JCI Insight ◽  
2019 ◽  
Vol 4 (12) ◽  
Author(s):  
Parker N. Hyde ◽  
Teryn N. Sapper ◽  
Christopher D. Crabtree ◽  
Richard A. LaFountain ◽  
Madison L. Bowling ◽  
...  

2014 ◽  
Vol 2 (S1) ◽  
Author(s):  
Eugene J Fine ◽  
C Segal-Isaacson ◽  
Silvia Herzkopf ◽  
Joseph Sparano ◽  
Maria Romano ◽  
...  

2006 ◽  
Vol 3 (1) ◽  
Author(s):  
Gualberto Ruaño ◽  
Andreas Windemuth ◽  
Mohan Kocherla ◽  
Theodore Holford ◽  
Maria Luz Fernandez ◽  
...  

Metabolism ◽  
2009 ◽  
Vol 58 (12) ◽  
pp. 1769-1777 ◽  
Author(s):  
Jeff S. Volek ◽  
Kevin D. Ballard ◽  
Ricardo Silvestre ◽  
Daniel A. Judelson ◽  
Erin E. Quann ◽  
...  

2018 ◽  
Vol 36 (6_suppl) ◽  
pp. 382-382
Author(s):  
Stephen J. Freedland ◽  
Jenifer Allen ◽  
Andrew J. Armstrong ◽  
Judd W. Moul ◽  
Howard M. Sandler ◽  
...  

382 Background: Nearly one third of men treated with curative intent for localized prostate cancer (PC) will develop a rising PSA. The rate of PSA rise (PSA doubling time aka PSASDT) is a predictor metastases and PC death. In laboratory mice, an extreme low carbohydrate diet slows PC growth. We tested whether this diet could slow PSADT in men with recurrent PC. Methods: We are conducting a 6-month multi-center randomized phase II trial of dietary carbohydrate restriction vs. no diet intervention control. Men had to have a BMI ≥24 kg/m2, received radical prostatectomy or definitive local radiation for PC, had a PSA 0.4-20.0 ng/ml (3-20 if prior radiation therapy) within the past 3 months, and current PSADT 3-36 months. The intervention arm was instructed to eat < 20 grams/carbs/day with no other limits. The control arm was told to make no diet. In this interim analysis, we present the efficacy of the dietary intervention with regards to weight loss. Arms were compared using rank-sum. Total anticipated enrollment is 60. The primary outcome is differences in PSADT between arms. Secondary outcomes include weight loss, and dietary make-up. Results: To date, 28 patients (14 in each study arm) have completed the study. Characteristics were well-balanced at baseline. At the 6-month dietary assessment, calorie consumption was similar between the two study arms (p = 0.090) among the 16 patients (7 low-carb, 9 control) with diet information. Subjects in the low-carb arm ate fewer carbs (29 vs. 188 g, p = 0.008) and more protein (125 vs. 73 g, p = 0.044) but similar amounts of fat (75 vs. 67 g, p = 0.672) vs. subjects in the control arm. Six months on the low carb diet resulted in greater weight loss (median: 31.7 vs. 0.8 lbs, p < 0.001), lower BMI (24.4 vs. 29.6 kg/m2, p < 0.001), and smaller waist circumference (95.7 vs. 108.9 cm, p = 0.002). Conclusions: In this interim analysis of an on-going dietary study for men with a rising PSA after definitive local treatment, an extreme low carbohydrate diet results in dramatic weight loss in 6 months. Whether this weight loss slows PC growth is an on-going question. Clinical trial information: NCT01763944.


Sign in / Sign up

Export Citation Format

Share Document